Special Master Says DLA Piper Can Rep Co. Suing Amgen Unit
A special master in Delaware has recommended clearing DLA Piper to represent a Dutch developer of biomedical mice in the company's patent lawsuit against a rival recently purchased by Amgen, despite...To view the full article, register now.
Already a subscriber? Click here to view full article